Dan Gasby, a television producer, author, and Alzheimer’s disease advocate, is teaming up with the nonprofit American Brain Foundation (ABF) to…
Articles by Charles Moore
Cognition Therapeutics has announced the dosing of the first Alzheimer’s patient in a Phase 1b clinical trial of its drug candidate, CT1812,…
Dr. David Satcher, the former U.S. Surgeon General, was named to the Board of Directors of UsAgainstAlzheimers (UsA2), where he…
Cure Alzheimer’s Fund, a Massachusetts-based nonprofit dedicated to funding promising research into ways to prevent, slow, or reverse Alzheimer’s…
A new study by researchers at Rice University in Houston used computer simulations to explore the beginnings of the molecular…
NeuroTherapia, a Cleveland Clinic spin-off biotech company, has received a $1.7 million funding commitment from the Alzheimer’s Drug Discovery…
Neurotrope BioScience has submitted an amended protocol to the U.S. Food and Drug Administration (FDA) for a Phase 2b clinical…
Quest Diagnostics has announced the release of CogniSense, its digital cognitive assessment tool to assist physicians in diagnosing,…
Alzheimer’s disease has been described in medical literature for more than a century, but still has no effective treatments. Now, scientists at…
Results of a new study published in the Journal of Alzheimer’s Disease by a team of researchers…